Check out the latest podcast here. In this episode, Michael and I discuss news regarding the FDA-approved treatment Evrysdi, and Michael’s decision to switch to this therapy. We also talk about the clinical trial drug SRK-015, which is developed by Scholar Rock. Finally, I read excerpts from some of our recent columns.
Hope you enjoy listening!
Do you have any takeaways from this episode? Any questions regarding Evrysdi or SRK-015?
SMA News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.